Olympia Financial Group Inc. (TSX:OLY)

CTI BioPharma Ratios and Metrics

Market cap in millions CAD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 1, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	305	259	231	166	112	96
Market Cap Growth	0.10%	12.19%	39.11%	48.31%	17.06%	-22.47%
Enterprise Value	277	246	223	158	99	88
Last Close Price	126.85	103.71	86.34	57.97	37.03	29.80
PE Ratio	12.95	10.84	9.64	11.73	17.20	11.98
PS Ratio	2.97	2.52	2.31	2.30	2.29	1.97
PB Ratio	7.10	6.18	6.54	6.56	5.96	5.06
P/TBV Ratio	7.92	6.70	7.67	8.96	11.04	5.76
P/FCF Ratio	11.57	12.54	12.42	20.31	9.63	7.61
P/OCF Ratio	11.43	12.36	12.19	19.42	9.43	7.50
EV/Sales Ratio	2.70	2.39	2.23	2.19	2.03	1.82
EV/EBITDA Ratio	8.48	7.51	6.71	7.80	9.76	7.62
EV/EBIT Ratio	9.05	7.93	7.08	8.51	10.41	7.97
EV/FCF Ratio	10.51	11.90	12.02	19.32	8.54	7.03
Debt / Equity Ratio	0.05	0.06	0.10	0.25	0.74	0.32
Debt / EBITDA Ratio	0.07	0.07	0.11	0.31	1.26	0.49
Debt / FCF Ratio	0.08	0.11	0.19	0.78	1.19	0.48
Asset Turnover	1.62	2.13	2.36	1.95	1.46	1.55
Inventory Turnover	-	-	-	-	90.03	54.22
Quick Ratio	2.38	4.63	3.19	2.15	1.35	1.62
Current Ratio	2.55	5.36	3.49	2.55	1.50	2.07
Return on Equity (ROE)	59.15%	61.94%	79.00%	64.19%	34.56%	42.71%
Return on Assets (ROA)	30.18%	40.08%	46.58%	31.34%	17.73%	22.17%
Return on Capital (ROIC)	44.35%	46.63%	55.96%	36.13%	20.74%	26.98%
Return on Capital Employed (ROCE)	71.20%	73.90%	88.20%	70.50%	47.70%	58.30%
Earnings Yield	7.72%	9.23%	10.37%	8.52%	5.82%	8.35%
FCF Yield	8.64%	7.98%	8.05%	4.92%	10.39%	13.15%
Dividend Yield	5.68%	6.94%	6.72%	5.45%	7.45%	9.26%
Payout Ratio	73.48%	72.44%	58.26%	53.73%	102.00%	83.14%
Total Shareholder Return	5.56%	6.94%	6.72%	5.45%	7.45%	9.26%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.